Evidence map›Paper›PMID 25000408›Full record

ArticlePloS one2014

Association of serum 25-hydroxyvitamin D with lifestyle factors and metabolic and cardiovascular disease markers: population-based cross-sectional study (FIN-D2D).

Maija E Miettinen, Leena Kinnunen, Jaana Leiviskä, Sirkka Keinänen-Kiukaanniemi, Eeva Korpi-Hyövälti, Leo Niskanen, Heikki Oksa, Timo Saaristo, Jaakko Tuomilehto, Mauno Vanhala and 2 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 37 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Observational
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. A therapeutic role for vitamin D on obesity-associated inflammation and weight-loss intervention.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2015
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 3 countries.

Maija E MiettinenDiabetes Prevention Unit, National Institute for Health and Welfare, Helsinki, Finland.
Leena KinnunenDiabetes Prevention Unit, National Institute for Health and Welfare, Helsinki, Finland.
Jaana LeiviskäDisease Risk Unit, National Institute for Health and Welfare, Helsinki, Finland.
Sirkka Keinänen-KiukaanniemiInstitute of Health Sciences, University of Oulu, Oulu, Finland; Unit of Primary Health Care, Oulu University Hospital, Oulu, Finland.
Eeva Korpi-HyövältiDepartment of Internal Medicine, South Ostrobothnia Central Hospital, Seinäjoki, Finland.
Leo NiskanenFinnish Medicines Agency, Helsinki, Finland; Faculty of Health Sciences, University of Eastern Finland, Kuopio, Finland.
Heikki OksaTampere University Hospital, Tampere, Finland.
Timo SaaristoPirkanmaa Hospital District, Tampere, Finland; Finnish Diabetes Association, Tampere, Finland.
Jaakko TuomilehtoDiabetes Prevention Unit, National Institute for Health and Welfare, Helsinki, Finland; Department of Internal Medicine, South Ostrobothnia Central Hospital, Seinäjoki, Finland; Center for Vascular Prevention, Danube-University Krems, Krems, Austria; King Abdulaziz University, Jeddah, Saudi Arabia.
Mauno VanhalaFaculty of Health Sciences, University of Eastern Finland, Kuopio, Finland; Primary Health Care Unit, Central Finland Central Hospital, Jyväskylä, Finland.
Matti UusitupaInstitute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio, Finland; Research Unit, Kuopio University Hospital, Kuopio, Finland.
Markku PeltonenDepartment of Chronic Disease Prevention, National Institute for Health and Welfare, Helsinki, Finland.
Finnish Institute for Health and Welfare · FICentral Finland Health Care District · FIFinnish Medicines Agency Fimea · FIKuopio University Hospital · FIOulu University Hospital · FIPirkanmaa Hospital District · FITampere University Hospital · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesLow serum 25-hydroxyvitamin D (25OHD) level has been associated with an increased risk of several chronic diseases. Our aim was to determine lifestyle and clinical factors that are associated with 25OHD level and to investigate connection of 25OHD level with metabolic and cardiovascular disease markers.

designIn total, 2868 Finnish men and women aged 45-74 years participated in FIN-D2D population-based health survey in 2007. Participants that had a serum sample available (98.4%; n = 2822) were included in this study. 25OHD was measured with chemiluminescent microparticle immunoassay method.

resultsThe mean 25OHD level was 58.2 nmol/l in men (n = 1348) and 57.1 nmol/l in women (n = 1474). Mean 25OHD level was lower in the younger age groups than in the older ones (p<0.0001 both in men and women). This study confirmed that low physical activity (p<0.0001 both in men and women), smoking (p = 0.0002 in men and p = 0.03 in women) and high BMI (p<0.0001 in women) are factors that independently associate with low 25OHD level. Of the metabolic and cardiovascular disease markers high triglyceride concentration (p = 0.02 in men and p = 0.001 in women) and high apolipoprotein B/apolipoprotein A1 ratio (p = 0.04 in men and p = 0.03 in women) were independently associated with low 25OHD level.

conclusionsHigher age did not predict lower 25OHD level in this study population of aged 45-74 years which may derive from a healthy life-style of "active pensioners". Low physical activity and smoking came up as independent lifestyle factors associated with low 25OHD level. Defining the molecular mechanisms behind the associations of 25OHD with low physical activity and smoking are important objective in future studies. The association of 25OHD with BMI, high triglyceride concentration and apolipoprotein B/apolipoprotein A1 ratio may be related to the role of vitamin D in inflammation, but more detailed studies are needed.

Indexed as

Life StyleAgedBiomarkersCardiovascular DiseasesCross-Sectional StudiesFemaleFinlandGlucoseHumansMaleMetabolic SyndromeMiddle AgedVitamin D25-hydroxyvitamin DBiomarkersGlucoseVitamin D

Identifiers

PMID25000408
PMCPMC4085035
OpenAlexW2091573033

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.